| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010300A1 Interaction trap system for isolating novel proteins |
| 05/11/1994 | WO1994010294A1 Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
| 05/11/1994 | WO1994010208A1 Diagnostic assay for latent matrix metalloproteinase no. 9 |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994009825A1 DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS INVOLVING A 92 kD GELATINASE |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009818A1 Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination |
| 05/11/1994 | WO1994009817A1 Novel antibody construct |
| 05/11/1994 | WO1994009811A1 An adhesion molecule |
| 05/11/1994 | WO1994009809A1 Method for preventing or treating liver disease |
| 05/11/1994 | WO1994009805A2 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/11/1994 | WO1994009765A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 05/11/1994 | EP0596725A2 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/11/1994 | EP0596479A2 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0596031A1 Neural calcium-activated neutral proteinase inhibitors |
| 05/11/1994 | EP0596011A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 05/11/1994 | EP0595997A1 PROTEIN V: A NOVEL IgG BINDING FACTOR |
| 05/11/1994 | EP0595993A1 Isolation of charged particles from fluids |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595865A1 Assay methods and compositions for detecting serum proteases, particularly activated protein c |
| 05/11/1994 | EP0595860A1 DNAs ENCODING PROTEINS ACTIVE IN LYMPHOCYTE-MEDIATED CYTOTOXICITY |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | EP0489771B1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES |
| 05/11/1994 | EP0463138B1 Drug for improving the reactions of the ovary and the production of ova and embryos in domestic mammals in connection with biotechnological embryo transfer |
| 05/11/1994 | DE4237502A1 Medicaments contg. anti-idiotype-CD14 antibodies - having high endotoxin binding capacity, used for treating e.g. infections, burns, ARDS, septic shock or psoriasis |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | CA2126967A1 Novel antibody construct |
| 05/11/1994 | CA2124694A1 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/10/1994 | US5310885 Process for immobilizing a protein containing substance on a solid phase |
| 05/10/1994 | US5310877 Ultrafiltration using an altered substrate microfilter impregnated with solid particles |
| 05/10/1994 | US5310875 Antiallergens |
| 05/10/1994 | US5310874 Immunoassay |
| 05/10/1994 | US5310729 Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions |
| 05/10/1994 | US5310688 Method and apparatus for eluting proteins in affinity membrane process |
| 05/10/1994 | US5310655 Process for the detection of kidney tubule functioning |
| 05/10/1994 | US5310653 Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis |
| 05/10/1994 | US5310551 Method for inhibiting pulmonary oxygen toxicity |
| 05/10/1994 | US5310535 Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 05/10/1994 | CA1329446C Peptides with laminin activity |
| 05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/04/1994 | EP0595743A1 Bihaptinic derivatives for binding for technetium or rhenium, process for their preparation, application for diagnosis and therapy, kits and immunological reactants comprising them |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595638A2 Epitope-related peptides of human parvovirus |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595241A2 Determination and inhibition of malic enzyme in tumor cells |
| 05/04/1994 | EP0594879A1 Cathepsin L-specific monoclonal antibodies, hybridomas for producing the same and a method of using the same |
| 05/04/1994 | EP0594843A1 Antibody assay for amylin |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594710A1 Tyrosine kinase |
| 05/04/1994 | EP0594624A1 Dynemicin analogs: syntheses, methods of preparation and use |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594576A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/03/1994 | US5308835 Cloning, gene expression, vaccine against diarrheal diseases including cholera |
| 05/03/1994 | US5308769 Polyacrylamide gel electrophoresis with reducing conditions |
| 05/03/1994 | US5308753 Methods for purifying and detecting IGM antibodies |
| 05/03/1994 | US5308752 Determination of antibody binding to dystrophin-protein complex |
| 05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |
| 05/03/1994 | US5308614 Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/28/1994 | WO1994009369A1 Method for screening hiv-1 positive individuals using antibodies against sulfatide |
| 04/28/1994 | WO1994009368A1 Particles having gelatin-aminodextran coatings of and processes for making same |
| 04/28/1994 | WO1994009155A1 Methods of detecting alzheimer's disease |
| 04/28/1994 | WO1994009150A1 Monoclonal antibodies to prostate cells |
| 04/28/1994 | WO1994009149A1 Monoclonal antibody |
| 04/28/1994 | WO1994009142A1 Vaccine containing a thiol protease |
| 04/28/1994 | WO1994009137A1 Antibodies against type 2 tumor necrosis factor receptor |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009135A1 Cyclin complex rearrangement and uses related thereto |
| 04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
| 04/28/1994 | WO1994009117A1 Direct selection of cells by secretion product |
| 04/28/1994 | WO1994009038A1 Process for producing native intravenously administrable stabilised immunoglobin |
| 04/28/1994 | WO1994009034A1 Clot directed anticoagulant, process for making same and methods of use |
| 04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 04/28/1994 | WO1994008621A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | WO1994008620A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | WO1994008615A1 Antibody to naturally-occurring aminomalonic acid and uses therefor |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008601A1 Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates |